- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00744094
Resistance Training in Elderly
September 22, 2015 updated by: Maastricht University Medical Center
The Influence of Resistance Training on Body Composition and Muscle Characteristics in Healthy Elderly
In the present study the investigators aim to determine whether protein supplementation can augment the response to a 12 week resistance training program in healthy elderly men.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
26
Phase
- Phase 2
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Maastricht, Netherlands, 6200MD
- Maastricht University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years to 85 years (Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Living independently
Exclusion Criteria:
- Diabetes
- Cardiovascular disease
- Orthopedic limitations
- Any disorder known to compromise ability for resistance training
- History of resistance training in past 5 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: 1
placebo drink
|
12 weeks resistance training, 3 days per week
|
|
Experimental: 2
protein drink
|
12 weeks resistance training, 3 days per week
250 ml protein hydrolysate solution
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Muscle mass measured at limb and cellular level
Time Frame: before and after 12 weeks of intervention
|
before and after 12 weeks of intervention
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Muscle strength
Time Frame: before and after 12 weeks of intervention
|
before and after 12 weeks of intervention
|
|
Body composition
Time Frame: before and after 12 weeks of intervention
|
before and after 12 weeks of intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Luc JC van Loon, PhD, Maastricht University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2007
Primary Completion (Actual)
September 1, 2007
Study Completion (Actual)
July 1, 2008
Study Registration Dates
First Submitted
August 28, 2008
First Submitted That Met QC Criteria
August 28, 2008
First Posted (Estimate)
August 29, 2008
Study Record Updates
Last Update Posted (Estimate)
September 23, 2015
Last Update Submitted That Met QC Criteria
September 22, 2015
Last Verified
August 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MEC 06-3-062B
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atrophy
-
Hillel Yaffe Medical CenterRecruitingVaginal Atrophy | Vulvar AtrophyIsrael
-
BionovoUnknownVaginal Atrophy | Vulvar AtrophyUnited States
-
Sun Pharmaceutical Industries LimitedTerminated
-
United States Army Research Institute of Environmental...CompletedMuscular Disorders, Atrophic | Muscle Atrophy | Disuse Atrophy | Atrophy, Disuse | Disuse Atrophy Muscle of ThighUnited States
-
Robert WestermannWithdrawnMuscle Atrophy | ACL Tear | Quadriceps Muscle Atrophy | Muscle Atrophy, ProximalUnited States
-
University of JazanCompletedQuadriceps Muscle AtrophySaudi Arabia
-
DLR German Aerospace CenterCompletedMuscle; Atrophy, GeneralGermany
-
McMaster UniversityTerminatedSarcopenia | Muscle Atrophy | Muscle Disuse AtrophyCanada
-
Petra LarmoTurun Gynekologikeskus Oy; Tekes - The Finnish Funding Agency for Technology...CompletedVaginal Atrophy | Vaginal Dryness | Vulvar Atrophy | Vulvar DrynessFinland
-
Sunnybrook Health Sciences CentreInnovation Fund of the Alternative Funding Plan from the Academic Health...Active, not recruiting
Clinical Trials on Resistance training
-
University of KasselCompleted
-
Vienna Hospital AssociationCompleted
-
University of KasselUniversity of PotsdamCompleted
-
University of Alabama at BirminghamCompletedMusculoskeletal and Metabolic CrosstalkUnited States
-
University of Applied Sciences of Western SwitzerlandCompleted
-
University of BarcelonaCompleted
-
Queens College, The City University of New YorkNational Institute on Aging (NIA)Recruiting
-
Universidade Federal de Sao CarlosConselho Nacional de Desenvolvimento Científico e TecnológicoCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
Universidade Federal do Triangulo MineiroUnknown